Company Filing History:
Years Active: 2016-2019
Title: Innovations of Aaron Muth
Introduction
Aaron Muth is an accomplished inventor based in Orlando, Florida. He has made significant contributions to the field of anti-cancer therapies, holding a total of four patents. His work focuses on developing novel compounds that target metastatic cancers, showcasing his commitment to advancing medical science.
Latest Patents
One of Aaron Muth's latest patents is titled "Anti-metastatic agents predicated upon polyamine macrocyclic conjugates." This patent discloses novel motuporamine compounds that act as anti-metastatic agents with low toxicity and high anti-migration activity. These non-toxic agents can be administered to patients with potential or actual metastatic cancers, such as pancreatic cancers, either alone or in combination with existing therapies to help inhibit tumor growth and spread.
Another significant patent is "Polyamine transport selective therapeutic agents with enhanced stability." This patent reveals di-substituted aryl polyamine compounds and methods for their production and use. These compounds serve as PTS targeting agents, selectively targeting the polyamine transport system with high efficacy and improved stability in the presence of amine oxidases.
Career Highlights
Aaron Muth is affiliated with the University of Central Florida Research Foundation, Inc., where he continues to innovate and contribute to research in cancer therapies. His work has the potential to significantly impact the treatment of metastatic cancers, providing new hope for patients.
Collaborations
Aaron has collaborated with notable colleagues, including Otto Phanstiel and Otto Phanstiel IV. These partnerships enhance the research and development of his innovative compounds.
Conclusion
Aaron Muth's contributions to the field of anti-cancer therapies through his patents demonstrate his dedication to improving patient outcomes. His innovative work continues to pave the way for advancements in cancer treatment.